(±)-Pirbuterol is a synthetic compound classified as a selective β2-adrenergic agonist, primarily used in the management of asthma and chronic obstructive pulmonary disease (COPD). It acts by stimulating β2-adrenergic receptors in the bronchial smooth muscle, leading to bronchodilation and improved airflow. The substance is characterized by its chiral nature, existing as a racemic mixture of two enantiomers, which can influence its pharmacological activity and side effects. (±)-Pirbuterol is typically administered via inhalation, allowing for targeted delivery to the lungs, and is known for its rapid onset of action. Its chemical structure includes a phenolic group and a secondary amine, contributing to its activity and solubility properties. The compound is generally well-tolerated, though potential side effects may include tremors, tachycardia, and nervousness, which are common to β2-agonists. As with any medication, it is essential to use (±)-Pirbuterol under medical supervision to ensure safety and efficacy in treating respiratory conditions.

(±)-Pirbuterol

38677-81-5: (±)-Pirbuterol, α6-[[(1,1-Dimethylethyl)amino]methyl]-3-hydroxy-2,6-pyridinedimethanol, ARA 211, Pirbuterol, 2,6-Pyridinedimethanol, α6-[[(1,1-dimethylethyl)amino]methyl]-3-hydroxy-

Pirbuterol

Pirbuterol Dihydrochloride

Pirbuterol, a short-acting β2 adrenoreceptor agonist, has bronchodilating action used in the treatment of asthma.

CAS 38677-81-5: (±)-Pirbuterol

Pirbuterol

Ref: 4Z-P-359001

Pirbuterol Dihydrochloride

Ref: 86-MM3196.00

Pirbuterol

Ref: TM-T28421